Digital Health Tech in Clinical Trials Market: By Technology, By Clinical Phase, By Application, By End User, Medical Device Manufacturers, and Academic & Research Institutes), and Region Forecast 2019-2030
Digital Health Tech in Clinical Trials Market size was valued at US$ 7,392.5 million in 2023, at a CAGR of 11.3% during the forecast period (2024-2030). The growing need for effective, data-driven clinical trials and the uptake of cutting-edge digital technologies are driving the market. Trial costs and timeframes have been greatly reduced by wearable technology, artificial intelligence, and telemedicine systems, which have transformed patient monitoring, data collecting, and remote trial administration. The market is developing even faster due to the increasing demand for decentralized clinical trials and real-time data.
However, there are barriers to adoption that may discourage smaller businesses, such as worries about data protection, legal requirements, and the high upfront cost of implementing these technologies. Opportunities lay in expanding digital health platforms into new regions and employing AI and machine learning to boost trial accuracy and patient recruiting procedures. There's also a lot of promise when integrating blockchain for safe data management. Notable developments include the rising usage of decentralized trials, AI integration for trial optimization and prediction results, and real-time analytics of patient data. To guarantee patient compliance and safety, wearable technology and telemedicine are also becoming more and more popular.
The digital health tech in clinical trials market size is inclusive of several companies such as Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE HealthCare (US), Abbott (US), DMRON Corporation (Japan), Fitbit, Inc. (A Google Company) (US), Johnson & Johnson Private Limited (US), Siemens Healthineers AG (Germany), Masimo (US), Apple, Inc. (US), Merative (US), AT &T, Inc. (US), eClinicalWorks (US), AirStrip Technologies, Inc (US), AdvancedMD, Inc. (US), and Medidata Solutions, Parexel, IQVIA, Dassault Systèmes, Oracle Health Sciences, eClinicalWorks, CRF Health, Covance (Labcorp Drug Development), Clario, and Bioclinica.
• In February 2023, Medidata Solutions introduced a novel AI-powered platform to improve patient acquisition and trial efficacy.
• In July 2022, IQVIA announced the extension of their decentralized clinical trial (DCT) solutions, which now include remote monitoring capabilities and powerful analytics.
• In March 2023, to expedite data gathering and analysis in clinical trials, Oracle Health Sciences introduced a cloud-based e-clinical platform.
By Technology: The two major most prominent technologies in the digital health tech in clinical trials market are machine learning (ML) and artificial intelligence (AI). These technologies are becoming more and more popular because of their capacity to analyze large volumes of data rapidly, which enhances decision-making in clinical trials. Trials may be conducted more effectively and economically by using AI and ML to improve data analysis, optimize trial designs, and predict patient outcomes. They are essential instruments that are used to aid in patient recruiting, monitoring, and data administration. The need for accuracy, speed, and precision in clinical trials particularly in intricate investigations like personalized medicine or oncology further propels the domination of AI and ML.
By Clinical Phase: In the digital health tech in clinical trials market, Phase III clinical trials are the most dominant. Phase III trials involve large-scale testing of a treatment's efficacy and safety on a broader population, which requires extensive data collection and analysis. The complexity and cost of these trials make digital technologies essential for improving efficiency and accuracy. Digital health tools, such as remote patient monitoring, electronic data capture, and AI-driven analytics, streamline processes and reduce time and cost. The high stakes involved in proving a treatment's effectiveness before regulatory approval further drive the need for advanced digital technologies to optimize trial outcomes in this phase.
By Application: The most popular application of digital health technology in the clinical trials market is data collection and management. The foundation of clinical trials is reliable and efficient data gathering, which guarantees the validity of the results and compliance with regulations. Digital tools increase the speed, precision, and security of data gathering, making it easier to capture, store, and analyze massive volumes of trial data. AI-driven analytics, cloud-based platforms, and electronic data capture (EDC) are some of the technologies that make managing large, complicated datasets from several trial sites easier. The increasing intricacy of clinical trials, especially in the fields of precision medicine and large-scale research, has made sophisticated data management systems essential for maintaining regulatory compliance and enhancing trial results.
By End User: The primary end users in the digital health tech in clinical trials market are Pharmaceutical Companies. These businesses use digital health technology to improve clinical trial accuracy and efficiency. Pharmaceutical businesses may decrease costs, speed up the time it takes to sell new treatments and optimize their research operations by using modern systems for data collecting, patient monitoring, and analytics. Robust digital systems that can manage big datasets and enhance patient involvement are required due to the growing demand for individualized treatment and the requirement for increasingly intricate clinical trial designs. Pharmaceutical corporations utilize cutting-edge technology that guarantees compliance and enhances trial quality in response to regulatory requirements for expedited medication approvals, further consolidating their position as the market's main end users.
Study Period
2024 - 2030Base Year
2023CAGR
11.3%Largest Market
Asia PacificFastest Growing Market
North America
The growing need for effective and affordable solutions for clinical trial procedures is driving the market for digital health technology in clinical trials. Digital health technologies like e-consent, telemedicine, and remote patient monitoring have become more popular as a result of growing healthcare expenses and the difficulty of conducting clinical studies. The COVID-19 pandemic has prompted a move towards decentralized clinical trials (DCTs), which in turn has increased demand for digital solutions that support patient enrolment, data gathering, and real-time tracking. In addition, the industry is moving toward more sophisticated digital tools as a result of the increasing use of artificial intelligence (AI) and machine learning (ML) in the analysis of clinical data. These technologies improve overall efficiency and shorten trial times.
The market for digital health technology in clinical trials is growing quickly, but there are a few obstacles in its path. The legislative ambiguity surrounding the use of digital technology in clinical trials is one of the main obstacles, particularly in areas with strict compliance requirements. Small and medium-sized pharmaceutical businesses may find it difficult to adopt digital platforms and solutions due to the significant upfront costs involved. Additionally, because clinical trials handle sensitive health data, privacy and data security considerations are quite important. Additionally, the adoption of digital health products is hampered by the inadequate technology infrastructure in underdeveloped nations. All of these things work together to impede market penetration and broad acceptance.
There are several development prospects in the clinical trials market for digital health technology, especially with the growing popularity of hybrid and decentralized clinical trials. The emergence of wearable technology and mobile health applications presents a distinct opportunity for businesses to obtain real-time data from patients who are located distant. Additionally, AI and machine learning present untapped potential for evaluating huge volumes of clinical trial data, making trial processes more efficient and precise. Clinical trial records may be kept safe and unchangeable with the use of blockchain technology. Companies may use these solutions internationally by expanding their digital infrastructure in developing regions. This addresses the drawbacks of traditional trial models and enhances patient access and involvement.
The increasing use of wearable technology and mobile health applications for real-time data collecting, and improving patient monitoring and engagement, is one of the major trends in the clinical trials market for digital health technology. The COVID-19 pandemic has prompted a move toward decentralized clinical trials (DCTs), which are changing the way studies are carried out by enabling distant participation and monitoring. The growing use of artificial intelligence (AI) and machine learning (ML) for data analysis, which helps shorten trial times and increase accuracy, is another trend. Blockchain technology is becoming more and more popular since it can offer transparent, safe trial data recordings. Additionally, patient-centric strategies that emphasize compliance and ease through digital health technologies are receiving greater attention.
Due to the nation's sophisticated healthcare system and robust regulatory frameworks that support innovation, the US digital health tech in the clinical trials market is a dominating participant. The use of wearable technology, remote patient monitoring systems, telemedicine, and other digital health technologies is being further accelerated by the growing emphasis on decentralized clinical trials (DCTs). Prominent pharmaceutical corporations and IT businesses that invest in digital platforms to optimize clinical processes are important considerations.
Furthermore, the US clinical trial industry is changing due to the increased need for precision medicine as well as the use of AI and machine learning for data analysis. This has resulted in speedier, more patient-centered operations. Secure data processing is ensured by privacy legislation such as HIPAA. Due to its sophisticated technology infrastructure, robust regulatory environment, and substantial expenditures in clinical research, North America leads the global digital health tech in the clinical trials market. Europe is a growing market due to stricter rules governing clinical trial data and more government funding for digital health projects. Leading the way in digital technology usage in trials are nations like the UK and Germany.
The Asia-Pacific area is expanding rapidly due to increased clinical trial outsourcing, an increasing emphasis on healthcare digitalization, and an increase in pharmaceutical R&D in nations like China, Japan, and India. In Latin America and the Middle East & Africa, growth is sluggish but growing as healthcare systems modernize and digital health solutions become more accessible, particularly in urban areas.
North America has a highly developed market for digital health technologies in clinical trials, fueled by regulatory support for digital solutions and technological improvements. Because of its strong clinical research funding, extensive healthcare infrastructure, and expanding use of decentralized trials, the United States leads this region. To improve data quality and expedite clinical trials, major companies in the tech and pharmaceutical sectors are collaborating to include AI, machine learning, and blockchain. Though it lags somewhat behind the U.S. in terms of scale, Canada is also seeing growth in this industry as a result of increased clinical research efforts and government measures encouraging digital health solutions.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024 - 2030 |
|
Market Size in 2023 |
US$ 7,392.5 million |
|
Market CAGR |
11.3% |
|
By Technology |
|
|
By Clinical Phase |
|
|
By Application |
|
|
By End User |
|
|
By Region |
|
The market for digital health technology in clinical trials is expected to develop significantly since there is a growing need for improved patient involvement and remote patient monitoring. Advancements in AI and machine learning are fueling innovation, while the move towards decentralized clinical trials reflects shifting healthcare dynamics. Processes for gathering and managing data are predicted to be completely transformed by the merging of wearable technology and mobile health applications. There should be plenty of chances in the sector as long as regulatory backing remains strong and digital businesses and healthcare providers continue to collaborate. To guarantee further expansion, though, issues with patient privacy and data security must be resolved.
Download Free Sample Report
The global digital health tech in clinical trials market was valued at US$ 7,392.5 million in 2023, at a CAGR of 11.3% during the forecast period 2024-2030.
• The need for remote patient monitoring is growing
• Developments in machine learning and artificial intelligence
• The use of electronic health records (EHRs) is growing.
•Effective data management and gathering are essential for clinical studies.
• Integration of wearable technology to check health in real-time.
• Move in the direction of virtual clinical trials and telemedicine
Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE HealthCare (US), Abbott (US), DMRON Corporation (Japan), Fitbit, Inc. (A Google Company) (US), Johnson & Johnson Private Limited (US), Siemens Healthineers AG (Germany), Masimo (US), Apple, Inc. (US), Merative (US), AT &T, Inc. (US), eClinicalWorks (US), AirStrip Technologies, are the key companies in the digital health tech in clinical trials market.
| 1. Executive Summary |
| 2. Global Digital Health Tech in Clinical Trials Market Introduction |
| 2.1.Global Digital Health Tech in Clinical Trials Market - Taxonomy |
| 2.2.Global Digital Health Tech in Clinical Trials Market - Definitions |
| 2.2.1.Technology |
| 2.2.2.Clinical Phase |
| 2.2.3.Application |
| 2.2.4.End Users |
| 2.2.5.Region |
| 3. Global Digital Health Tech in Clinical Trials Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Digital Health Tech in Clinical Trials Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Digital Health Tech in Clinical Trials Market By Technology, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Wearable& Sensors |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Mobile Health Application |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Electronic Patient-Reported Outcome |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Telemedicine Solution |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. AI & ML Tools |
| 5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Blockchain Technology |
| 5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Big Data Analytics |
| 5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 5.8. Cloud Based Performance |
| 5.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.8.3. Market Opportunity Analysis |
| 6. Global Digital Health Tech in Clinical Trials Market By Clinical Phase, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Phase 1 |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Phase 2 |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Phase 3 |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Phase 4 |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7. Global Digital Health Tech in Clinical Trials Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Patient Monitoring |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Data Collection and Management |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Drug Development and Discovery |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Remote Patient Management |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Others |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. Global Digital Health Tech in Clinical Trials Market By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Pharmaceutical and Biotechnology Companies |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Contract Research Organizations (CROs) |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Medical Device Manufacturers |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Academic & Research Institutes |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 9. Global Digital Health Tech in Clinical Trials Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10. North America Digital Health Tech in Clinical Trials Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Wearable& Sensors |
| 10.1.2.Mobile Health Application |
| 10.1.3.Electronic Patient-Reported Outcome |
| 10.1.4.Telemedicine Solution |
| 10.1.5.AI & ML Tools |
| 10.1.6.Blockchain Technology |
| 10.1.7.Big Data Analytics |
| 10.1.8.Cloud Based Performance |
| 10.2. Clinical Phase Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Phase 1 |
| 10.2.2.Phase 2 |
| 10.2.3.Phase 3 |
| 10.2.4.Phase 4 |
| 10.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Patient Monitoring |
| 10.3.2.Data Collection and Management |
| 10.3.3.Drug Development and Discovery |
| 10.3.4.Remote Patient Management |
| 10.3.5.Others |
| 10.4. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Pharmaceutical and Biotechnology Companies |
| 10.4.2.Contract Research Organizations (CROs) |
| 10.4.3.Medical Device Manufacturers |
| 10.4.4.Academic & Research Institutes |
| 10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11. Europe Digital Health Tech in Clinical Trials Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Wearable& Sensors |
| 11.1.2.Mobile Health Application |
| 11.1.3.Electronic Patient-Reported Outcome |
| 11.1.4.Telemedicine Solution |
| 11.1.5.AI & ML Tools |
| 11.1.6.Blockchain Technology |
| 11.1.7.Big Data Analytics |
| 11.1.8.Cloud Based Performance |
| 11.2. Clinical Phase Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Phase 1 |
| 11.2.2.Phase 2 |
| 11.2.3.Phase 3 |
| 11.2.4.Phase 4 |
| 11.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Patient Monitoring |
| 11.3.2.Data Collection and Management |
| 11.3.3.Drug Development and Discovery |
| 11.3.4.Remote Patient Management |
| 11.3.5.Others |
| 11.4. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Pharmaceutical and Biotechnology Companies |
| 11.4.2.Contract Research Organizations (CROs) |
| 11.4.3.Medical Device Manufacturers |
| 11.4.4.Academic & Research Institutes |
| 11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12. Asia Pacific (APAC) Digital Health Tech in Clinical Trials Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Wearable& Sensors |
| 12.1.2.Mobile Health Application |
| 12.1.3.Electronic Patient-Reported Outcome |
| 12.1.4.Telemedicine Solution |
| 12.1.5.AI & ML Tools |
| 12.1.6.Blockchain Technology |
| 12.1.7.Big Data Analytics |
| 12.1.8.Cloud Based Performance |
| 12.2. Clinical Phase Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Phase 1 |
| 12.2.2.Phase 2 |
| 12.2.3.Phase 3 |
| 12.2.4.Phase 4 |
| 12.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Patient Monitoring |
| 12.3.2.Data Collection and Management |
| 12.3.3.Drug Development and Discovery |
| 12.3.4.Remote Patient Management |
| 12.3.5.Others |
| 12.4. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Pharmaceutical and Biotechnology Companies |
| 12.4.2.Contract Research Organizations (CROs) |
| 12.4.3.Medical Device Manufacturers |
| 12.4.4.Academic & Research Institutes |
| 12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13. Middle East and Africa (MEA) Digital Health Tech in Clinical Trials Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Wearable& Sensors |
| 13.1.2.Mobile Health Application |
| 13.1.3.Electronic Patient-Reported Outcome |
| 13.1.4.Telemedicine Solution |
| 13.1.5.AI & ML Tools |
| 13.1.6.Blockchain Technology |
| 13.1.7.Big Data Analytics |
| 13.1.8.Cloud Based Performance |
| 13.2. Clinical Phase Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Phase 1 |
| 13.2.2.Phase 2 |
| 13.2.3.Phase 3 |
| 13.2.4.Phase 4 |
| 13.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Patient Monitoring |
| 13.3.2.Data Collection and Management |
| 13.3.3.Drug Development and Discovery |
| 13.3.4.Remote Patient Management |
| 13.3.5.Others |
| 13.4. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Pharmaceutical and Biotechnology Companies |
| 13.4.2.Contract Research Organizations (CROs) |
| 13.4.3.Medical Device Manufacturers |
| 13.4.4.Academic & Research Institutes |
| 13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14. Latin America Digital Health Tech in Clinical Trials Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 14.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Wearable& Sensors |
| 14.1.2.Mobile Health Application |
| 14.1.3.Electronic Patient-Reported Outcome |
| 14.1.4.Telemedicine Solution |
| 14.1.5.AI & ML Tools |
| 14.1.6.Blockchain Technology |
| 14.1.7.Big Data Analytics |
| 14.1.8.Cloud Based Performance |
| 14.2. Clinical Phase Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Phase 1 |
| 14.2.2.Phase 2 |
| 14.2.3.Phase 3 |
| 14.2.4.Phase 4 |
| 14.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Patient Monitoring |
| 14.3.2.Data Collection and Management |
| 14.3.3.Drug Development and Discovery |
| 14.3.4.Remote Patient Management |
| 14.3.5.Others |
| 14.4. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Pharmaceutical and Biotechnology Companies |
| 14.4.2.Contract Research Organizations (CROs) |
| 14.4.3.Medical Device Manufacturers |
| 14.4.4.Academic & Research Institutes |
| 14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Koninklijke Philips N.V. (Netherlands) |
| 15.2.2.Medtronic (Ireland) |
| 15.2.3.GE HealthCare (US) |
| 15.2.4.Abbott (US) |
| 15.2.5.DMRON Corporation (Japan) |
| 15.2.6.Fitbit, Inc. (A Google Company) (US) |
| 15.2.7.Johnson & Johnson Private Limited (US) |
| 15.2.8.Siemens Healthineers AG (Germany) |
| 15.2.9.Masimo (US) |
| 15.2.10.Apple, Inc. (US) |
| 15.2.11.Merative |
| 15.2.12.eClinicalWorks (US) |
| 15.2.13.AirStrip Technologies, Inc (US) |
| 15.2.14.AdvancedMD, Inc. (US) |
| 15.2.15.Medidata Solutions |
| 15.2.16.Parexel |
| 15.2.17.IQVIA |
| 15.2.18.Dassault Systèmes |
| 15.2.19.Oracle Health Sciences |
| 15.2.20.eClinicalWorks |
| 15.2.21.CRF Health |
| 15.2.22.Covance (Labcorp Drug Development) |
| 15.2.23.Clario |
| 15.2.24.Bioclinica. |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Free Sample
